Table 2 Local control and overall survival were analyzed by clinical characteristics (univariate analyses)
From: Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma
Factor | No. | 2y–LC | p-value | 2y–OS | p-value |
|---|---|---|---|---|---|
Child-Pugh classification | |||||
A | 27 | 85.9% | 0.544 | 85.0% | 0.034 |
B | 4 | 100% | 37.5% | ||
Performance status | |||||
0 | 17 | 90.9% | 0.589 | 91.7% | 0.015 |
1, 2 | 14 | 82.5% | 64.6% | ||
MELD score | |||||
6, 7 | 17 | 93.3% | 0.705 | 81.8% | 0.707 |
8 ≤ | 14 | 80.8% | 75.5% | ||
Stage (UICC 7th edition) | |||||
I | 24 | 83.1% | 0.866 | 81.3% | 0.762 |
II, III | 7 | 100% | 71.4% | ||
Stage (BCLC) | |||||
A, B | 14 | 87.5% | 0.498 | 100% | 0.097 |
C | 17 | 87.1% | 67.2% | ||
Tumor size | |||||
< 45 mm | 14 | 90.0% | 0.387 | 100% | 0.540 |
45 mm ≤ | 17 | 86.2% | 62.2% | ||